Surgery Doctors in Saint Charles, MO Accepting Medicare

9 Surgery doctors found. Showing 1 - 9

Dr. Samuel J Rheinhardt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr Ste 201, Saint Charles, MO 63301 Phone: 636-669-2332

Dr. Thomas A Schneider Ii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-940-5710    Fax: 636-669-2401

Jennifer Marie Laplante, MD, PHD Surgery - Trauma Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr Ste 201, Saint Charles, MO 63301 Phone: 636-669-2332

Dr. Aislinn Sue Vaughan, MD Surgery - Surgical Oncology Medicare: Accepting Medicare Assignments Practice Location: 1475 Kisker Rd, Suite 185, Saint Charles, MO 63304 Phone: 636-498-5800    Fax: 636-669-2401

Dr. David L Mccollister, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-669-2332    Fax: 636-669-2401

Dr. Patrick Anthony Nero, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 400 1st Capitol Dr, Suite 201, Saint Charles, MO 63301 Phone: 636-669-2332

Pamela Sue Peigh, M.D. Surgery - Surgical Critical Care Medicare: Not Enrolled in Medicare Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-947-5662

Thomas Aquinas Schneider Jr., MD Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 1st Capitol Dr, Saint Charles, MO 63301 Phone: 636-947-5000    Fax: 636-947-5000

Rafi Fredman, MD Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 1551 Wall St Ste 420, Saint Charles, MO 63303 Phone: 636-329-4036    Fax: 636-206-2898

News Archive

CDRD, University of Ottawa sign affiliation agreement for drug development platform

The University of Ottawa and the Centre for Drug Research and Development (CDRD) today announced that they have signed an affiliation agreement that will allow researchers at the University of Ottawa to access CDRD's drug development infrastructure and expertise.

FDA grants orphan drug designation to Ultragenyx UX003 for treatment of MPS 7

Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced that the FDA Office of Orphan Products Development has granted orphan drug designation for UX003 for the treatment of MPS 7.

Investigational drug may hold benefit for patients with lung and ovarian cancers

In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.

BioImagene licenses Olympus patents in digital pathology, virtual microscopy

Olympus America Inc. has signed a nonexclusive worldwide licensing agreement with BioImagene, Inc. of Sunnyvale, California, allowing BioImagene to access an extensive portfolio of Olympus patents in the field of digital pathology and virtual microscopy. This is the most recent of several licenses that Olympus has granted for the technologies, which are considered critical for developing future digital imaging and data handling systems for pathology.

Read more Medical News

› Verified 5 days ago